Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease

被引:18
作者
Mills, JD [1 ]
Mansfield, MW [1 ]
Grant, PJ [1 ]
机构
[1] Univ Leeds, Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England
关键词
coronary artery disease; family history; hemostatic factors; insulin; exercise;
D O I
10.1161/hq0402.105902
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated levels of tissue-type plasminogen activator antigen (tPA), fibrinogen, and fibrin D-dimer predict coronary artery disease (CAD) events and stroke. These factors, possibly in association with insulin resistance, may be important in families in which CAD has become clinically apparent at a premature age. From 125 patients with angiographically confirmed, premature CAD, 175 healthy male relatives (age less than or equal to65 years) were identified. One hundred seventy-five healthy volunteers of similar age and without any family history of CAD were recruited. There were no differences between relatives and controls in terms of conventional CAD risk factors, cigarette smoking, alcohol consumption, or cardiorespiratory fitness. Estimated insulin resistance and plasminogen activator inhibitor I levels were not increased in relatives. Fibrin D-dimer, tPA, and fibrinogen levels were elevated in relatives compared with controls, 55 (52 to 58) ng/mL versus 49 (45 to 53) ng/mL, P<0.01, for D-dimer; 8.0 (7.5 to 8.6) ng/mL versus 5.6 (5.2 to 6.1) ng/mL, P<0.001, for tPA; and 3.0 (2.9 to 3.1) g/L versus 2.8 (2.7 to 2.9) g/L. P<0.05, for fibrinogen. These differences remained after adjustment for correlates, including fibrinogen. age for D-dimer, and features of the insulin resistance syndrome for tPA. tPA and D-dimer levels are elevated in the healthy, male, first-degree relatives of patients with premature CAD. This association is independent of potential confounding factors.
引用
收藏
页码:704 / 709
页数:6
相关论文
共 42 条
[1]  
BARA L, 1994, THROMB HAEMOSTASIS, V71, P434
[2]  
Carter AM, 1998, THROMB HAEMOSTASIS, V80, P632
[3]  
Chandler WL, 1997, CIRCULATION, V96, P761
[4]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[5]  
Danesh J, 2001, CIRCULATION, V103, P2323
[6]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[7]   Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Mykkänen, L ;
Tracy, RP ;
Zaccaro, DJ ;
Hales, CN ;
Haffner, SM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :562-568
[8]   Prospective study of fibrinolytic factors and incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Aleksik, N ;
Park, E ;
Salomaa, V ;
Juneja, H ;
Wu, KK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :611-617
[9]   Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study [J].
Gram, J ;
Bladbjerg, EM ;
Moller, L ;
Sjol, A ;
Jespersen, J .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (02) :205-212
[10]  
HAVERKATE F, 1995, THROMB HAEMOSTASIS, V73, P561